|
KIAA0947 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.46860000008687E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.28610000321916E-08 |
| Normal-vs-Stage2 |
4.239300E-03 |
| Normal-vs-Stage3 |
1.675650E-02 |
| Normal-vs-Stage4 |
2.36799999999704E-05 |
| Stage1-vs-Stage2 |
8.831000E-01 |
| Stage1-vs-Stage3 |
3.531000E-01 |
| Stage1-vs-Stage4 |
4.740600E-01 |
| Stage2-vs-Stage3 |
5.921200E-01 |
| Stage2-vs-Stage4 |
4.437200E-01 |
| Stage3-vs-Stage4 |
2.475600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.16350000026289E-07 |
| Normal-vs-AfricanAmerican |
1.97479999997086E-06 |
| Normal-vs-Asian |
3.383500E-03 |
| Caucasian-vs-AfricanAmerican |
6.077400E-01 |
| Caucasian-vs-Asian |
7.549000E-01 |
| AfricanAmerican-vs-Asian |
8.774800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.55860032949818E-10 |
| Normal-vs-Female |
9.745700E-02 |
| Male-vs-Female |
1.540460E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.71410000000028E-05 |
| Normal-vs-Extreme_Weight |
4.90679999964883E-08 |
| Normal-vs-Obese |
3.585100E-04 |
| Normal-vs-Extreme_Obese |
3.72530000000149E-05 |
| Normal_Weight-vs-Extreme_Weight |
7.135400E-01 |
| Normal_Weight-vs-Obese |
3.465600E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.960800E-01 |
| Extreme_Weight-vs-Obese |
1.286830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.356600E-01 |
| Obese-vs-Extreme_Obese |
2.517200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.438800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.569210E-04 |
| Normal-vs-Age(61-80Yrs) |
1.4647999480033E-09 |
| Normal-vs-Age(81-100Yrs) |
2.258600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.092200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.094200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.591800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.646400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.711200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.302200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.2455000060524E-09 |
| Normal-VS-Type2 PRCC |
2.72710000004395E-06 |
| Normal-VS-KIRP CIMP |
1.362420E-01 |
| Normal-VS-Unclassified PRCC |
1.836790E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.510800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.318000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.904200E-02 |
| Type2 PRCC-VS-KIRP CIMP |
7.301200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.932200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
5.270600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.46389994465568E-09 |
| Normal-vs-N1 |
2.052000E-01 |
| Normal-vs-N2 |
2.853000E-01 |
| N0-vs-N1 |
2.285800E-02 |
| N0-vs-N2 |
8.092000E-01 |
| N1-vs-N2 |
4.197800E-01 |
|
|
